Literature DB >> 17457303

Tumour microenvironment: laminin 332 in squamous-cell carcinoma.

M Peter Marinkovich1.   

Abstract

Basement membranes can be a barrier to tumour growth, but basement membrane molecules, including laminins, are also important autocrine factors produced by cancers to promote tumorigenesis. Many studies have shown the importance of laminin 332 (previously known as laminin 5) in this process, especially in squamous cell carcinoma. Through interactions with several cell-surface receptors (including alpha6beta4 and alpha3beta1 integrins, epidermal growth factor receptor and syndecan 1) and other basement membrane components (including type VII collagen), laminin 332 drives tumorigenesis through phosphatidylinositol-3 kinase (PI3K) and RAC1 activation, promoting tumour invasion and cell survival. The extracellular interactions of laminin 332 appear amenable to antibody-mediated therapies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17457303     DOI: 10.1038/nrc2089

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  128 in total

1.  Borrowing strength: a likelihood ratio test for related sparse signals.

Authors:  Ernst C Wit; David J G Bakewell
Journal:  Bioinformatics       Date:  2012-06-04       Impact factor: 6.937

2.  Squamous Cell Carcinoma - Similarities and Differences among Anatomical Sites.

Authors:  Wusheng Yan; Ignacio I Wistuba; Michael R Emmert-Buck; Heidi S Erickson
Journal:  Am J Cancer Res       Date:  2011-01-01       Impact factor: 6.166

3.  Laminin is required to orient epithelial polarity in the C. elegans pharynx.

Authors:  Jeffrey P Rasmussen; Sowmya Somashekar Reddy; James R Priess
Journal:  Development       Date:  2012-04-25       Impact factor: 6.868

Review 4.  Extracellular matrix composition reveals complex and dynamic stromal-epithelial interactions in the mammary gland.

Authors:  Ori Maller; Holly Martinson; Pepper Schedin
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-09-02       Impact factor: 2.673

5.  The role of a recombinant fragment of laminin-332 in integrin alpha3beta1-dependent cell binding, spreading and migration.

Authors:  Hironobu Yamashita; Manisha Tripathi; Mark P Harris; Shanshan Liu; Brandy Weidow; Roy Zent; Vito Quaranta
Journal:  Biomaterials       Date:  2010-03-27       Impact factor: 12.479

Review 6.  Integrin α3β1 as a breast cancer target.

Authors:  Sita Subbaram; C Michael Dipersio
Journal:  Expert Opin Ther Targets       Date:  2011-08-13       Impact factor: 6.902

Review 7.  The Yin and Yang of Integrin Function in Re-Epithelialization During Wound Healing.

Authors:  Manuela Martins-Green
Journal:  Adv Wound Care (New Rochelle)       Date:  2013-04       Impact factor: 4.730

8.  miR-1298 Inhibits Mutant KRAS-Driven Tumor Growth by Repressing FAK and LAMB3.

Authors:  Ying Zhou; Jason Dang; Kung-Yen Chang; Edwin Yau; Pedro Aza-Blanc; Jorge Moscat; Tariq M Rana
Journal:  Cancer Res       Date:  2016-10-01       Impact factor: 12.701

9.  N-Glycosylation of laminin-332 regulates its biological functions. A novel function of the bisecting GlcNAc.

Authors:  Yoshinobu Kariya; Rika Kato; Satsuki Itoh; Tomohiko Fukuda; Yukinao Shibukawa; Noriko Sanzen; Kiyotoshi Sekiguchi; Yoshinao Wada; Nana Kawasaki; Jianguo Gu
Journal:  J Biol Chem       Date:  2008-09-23       Impact factor: 5.157

10.  Loss of syndecan-1 is associated with malignant conversion in skin carcinogenesis.

Authors:  Mary Ann Stepp; Sonali Pal-Ghosh; Gauri Tadvalkar; Lamise Rajjoub; Rosalyn A Jurjus; Michael Gerdes; Andrew Ryscavage; Christophe Cataisson; Anjali Shukla; Stuart H Yuspa
Journal:  Mol Carcinog       Date:  2010-04       Impact factor: 4.784

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.